FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
18 July 20261 min read0 views
The FDA reviewed the drug under its program that promises ultra-fast reviews for promising medications that serve the public interest
Related Articles
0Technology33
Paris region deaths more than doubled during June heatwave: health authorities
The heatwave swept across Europe, breaking all-time temperature records in several countries
The Hindu
5 hours ago5
0Technology33
Monsoon and newborn care: what you need to know
The first 1,000 days, from conception to the second birthday, form a crucial period of a child’s life. Awareness about health hazards and infections a...
The Hindu
6 hours ago6
0Technology22
All you need to know about: Hepatitis C
Hepatitis C is now curable in most cases, but delayed diagnosis continues to drive liver disease and deaths worldwide
The Hindu
6 hours ago6
0Technology22
China's Kimi K3 challenges US AI leaders with frontier-level performance at lower cost
Chinese artificial intelligence startup Moonshot AI has unveiled its latest open-weight AI model, Kimi K3, with early results suggesting it could comp...
Firstpost.com
9 hours ago9